Inspire Medical Systems Inc Q3 2023 Earnings Call Summary - Thomson StreetEvents

Inspire Medical Systems Inc Q3 2023 Earnings Call Summary

Inspire Medical Systems Inc Q3 2023 Earnings Call Summary - Thomson StreetEvents
Inspire Medical Systems Inc Q3 2023 Earnings Call Summary
Published Nov 07, 2023
17 pages (10946 words) — Published Nov 07, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of INSP.N earnings conference call or presentation 7-Nov-23 10:00pm GMT

  
Brief Excerpt:

...A. We are excited to announce that during the third quarter, we surpassed the significant milestone of 50,000 patients treated with Inspire therapy, and the team is very proud to be able to make a difference in the lives of so many patients. B. In the third quarter, we generated revenue of $153.3 million, representing a 40% increase compared to the third quarter of 2022. C. Our growth continues to be driven by increased utilization at existing centers, and is complemented by the activation of new centers. D. Internationally, we grew 99% with the European team delivering very good results. E. We had several wins, including growth in Germany and the first full quarter of leveraging country-wide reimbursement in Belgium. F. Looking towards the fourth quarter in Europe, we are running up against inventory supply issues of polyurethane-based leads. G. We do not yet have our European Union Medical Device Regulation approval, commonly known as EU MDR, which allows us to start shipping the new...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Inspire Medical Systems Inc
Ticker
INSP.N
Time
10:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Danielle Joy Antalffy - UBS Investment Bank, Research Division - Analyst : Tim and Rick, just wanted to follow up on the comments around the prior auth just if you can give any context around how many centers were piloting this program? Just trying to get a sense of -- or if you can give us the number of what you think is -- how many procedures did not get done because of it? Anything you can get there? And I do have just one follow-up.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Maybe to follow-up on Danielle's, I'll ask both of them upfront. One, it said in the release you started to learn about this early in the third quarter. I imagine it probably overlapped with the second quarter call. So just wondering when you knew about it and why not mention on 2Q? And then as you look to '24, I realize it's still early, but I think it's important for investors. Any early thoughts you have, and how do you feel about where Street consensus is?

Table Of Contents

Inspire Medical Systems Inc at Truist Securities MedTech Conference Summary – 2024-06-18 – US$ 54.00 – Edited Brief of INSP.N presentation 18-Jun-24 2:40pm GMT

Inspire Medical Systems Inc at Truist Securities MedTech Conference Transcript – 2024-06-18 – US$ 54.00 – Edited Transcript of INSP.N presentation 18-Jun-24 2:40pm GMT

Inspire Medical Systems Inc at Jefferies Healthcare Conference Transcript – 2024-06-06 – US$ 54.00 – Edited Transcript of INSP.N presentation 6-Jun-24 3:30pm GMT

Inspire Medical Systems Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript – 2024-03-19 – US$ 54.00 – Edited Transcript of INSP.N presentation 19-Mar-24 2:30pm GMT

Inspire Medical Systems Inc Q3 2023 Earnings Call Transcript – 2023-11-07 – US$ 54.00 – Edited Transcript of INSP.N earnings conference call or presentation 7-Nov-23 10:00pm GMT

Inspire Medical Systems Inc at Wells Fargo Healthcare Conference Transcript – 2023-09-06 – US$ 54.00 – Edited Transcript of INSP.N presentation 6-Sep-23 3:00pm GMT

Inspire Medical Systems Inc Q2 2023 Earnings Call Transcript – 2023-08-01 – US$ 54.00 – Edited Transcript of INSP.N earnings conference call or presentation 1-Aug-23 9:00pm GMT

Inspire Medical Systems Inc at RBC Capital Markets Global Healthcare Conference Transcript – 2023-05-16 – US$ 54.00 – Edited Transcript of INSP.N presentation 16-May-23 5:35pm GMT

Inspire Medical Systems Inc at Bank of America Global Healthcare Conference Transcript – 2023-05-10 – US$ 54.00 – Edited Transcript of INSP.N presentation 10-May-23 5:00pm GMT

Inspire Medical Systems Inc Q1 2023 Earnings Call Transcript – 2023-05-02 – US$ 54.00 – Edited Transcript of INSP.N earnings conference call or presentation 2-May-23 9:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Inspire Medical Systems Inc Q3 2023 Earnings Call Summary" Nov 07, 2023. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2023-Inspire-Medical-Systems-Inc-Earnings-Call-B15762326>
  
APA:
Thomson StreetEvents. (2023). Inspire Medical Systems Inc Q3 2023 Earnings Call Summary Nov 07, 2023. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2023-Inspire-Medical-Systems-Inc-Earnings-Call-B15762326>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.